Contributed by NAMPA / AFP.
Press Release from Business Wire: OncoDNA
GOSSELIES, Feb 14, 2020 (BSW) - OncoDNA ("OncoDNA or "the Company"), the healthcare technology company making precision medicine a reality, today announced that it has completed a EUR19 million ($20 million) Series B equity financing. The new funding will support rapid international growth, accelerate software development and hiring initiatives.
The round was led by Vesalius Biocapital III and Swisscanto Invest by Zürcher Kantonalbank with the signif ...